Domestic markets navigated a volatile week, ending near all-time highs. Bajaj Finance filed for a Rs 7,000 crore IPO, Kronox Lab to debut with 30% premium, Godawari Power eyes share buyback, Dr Reddy’s unit gets FDA observations, and Jubilant Pharmova faces FDA scrutiny.
Will Ambani’s all-fresh Jio sale prove to be a masterstroke for investors?
Reliance Jio is set to roll out an ambitious Rs 30,213 crore IPO featuring solely new equity shares, not existing ones. In light of mixed